Cargando…

A comparison of subgroup identification methods in clinical drug development: Simulation study and regulatory considerations

With advancement of technologies such as genomic sequencing, predictive biomarkers have become a useful tool for the development of personalized medicine. Predictive biomarkers can be used to select subsets of patients, which are most likely to benefit from a treatment. A number of approaches for su...

Descripción completa

Detalles Bibliográficos
Autores principales: Huber, Cynthia, Benda, Norbert, Friede, Tim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6772173/
https://www.ncbi.nlm.nih.gov/pubmed/31270933
http://dx.doi.org/10.1002/pst.1951